Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$135.66 - $197.02 $124,128 - $180,273
-915 Reduced 44.48%
1,142 $175,000
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $39,302 - $69,733
332 Added 19.25%
2,057 $369,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $57,145 - $93,983
-484 Reduced 21.91%
1,725 $204,000
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $38,301 - $57,744
327 Added 17.38%
2,209 $316,000
Q1 2022

May 04, 2022

SELL
$126.46 - $235.05 $11,507 - $21,389
-91 Reduced 4.61%
1,882 $324,000
Q4 2021

Feb 07, 2022

BUY
$225.82 - $368.51 $445,542 - $727,070
1,973 New
1,973 $501,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.